PAID ADVERTISMENT

Learn about the latest advances

eP7_Story1_smallHear industry supporters share their expertise about the latest products and therapeutic treatments during Scientific Sessions 2016, Nov. 12-16, in New Orleans. Several interactive Cardiovascular Expert Theaters take place Sunday-Tuesday, Nov. 13-15, in the Science & Technology Hall. Enjoy complimentary lunch, provided by the American Heart Association, while being introduced to these developments that will help you in your cardiovascular practice.

Sunday, Nov. 13

11:15 a.m.-Noon
Interpreting Measures of Clinical Effectiveness in Cardiovascular Outcome Trials
Supporter: Amgen, Inc.
Booth #701                                                    

PRALUENT® (alirocumab) Injection: Long-Term Efficacy and Safety
Supporter: Sanofi – Regeneron
Booth #751

Thrombosis: AFib — An Exploration in Risk Reduction
Supporter: Janssen Pharmaceuticals
Booth #3661

12:30-1:15 p.m.
Putting Guidelines Into Practice: New Recommendations for Optimal Treatment of Heart Failure With Reduced Ejection Fraction (HF rEF)
Supporter: Novartis
Booth #3661

Repatha® (evolocumab): A Focused Clinical Review
Supporter: Amgen, Inc.
Booth #751

3-3:45 p.m.
Dyslipidemia and Inflammation: Emerging Strategies for Reducing Residual Risk in Patients With a History of Myocardial Infarction (MI)
Supporter: Novartis
Booth #3661

Monday, Nov. 14

10:15-11 a.m.
Doctor, I’m Dizzy: Clinical Perspectives of Neurogenic Orthostatic Hypotension
Supporter: Lundbeck
Booth #3661

Noon-12:45 p.m.
From Particles to Plaque: Mechanisms and Measurement of Atherosclerosis
Supporter: Amgen, Inc.
Booth #751

PRALUENT® (alirocumab) Injection: Efficacy and Safety With Two Different Dosing Options
Supporter: Sanofi – Regeneron
Booth #701

Treatment Approaches for Hypertension
Supporter: Allergan
Booth #3661

1:15-2 p.m.
Addressing Treatment Priorities in Heart Failure
Supporter: Novartis
Booth #751

Moving Forward With Reverse, a Multispecialty Perspective
Supporter: Boehringer Ingelheim
Booth #3661

Repatha® (evolocumab): A Focused Clinical Review
Supporter: Amgen, Inc.
Booth #701

3:15-4 p.m.
The Balancing Act of AHF Care: A Focus on Treatment, Outcomes and Economics
Supporter: Novartis
Booth #3661

Tuesday, Nov. 15

Noon-12:45 p.m.
Anticoagulation in Perspective
Supporter: Daiichi Sankyo, Inc.
Booth #751

The Diagnosis and Management of Atrial Fibrillation: Working Together to Reduce Stroke Risk in NVAF
Supporters: Boehringer Ingelheim and Medtronic
Booth #3661

From Particles to Plaque: Mechanisms and Measurement of Atherosclerosis
Supporter: Amgen, Inc.
Booth #701

1:15-2 p.m.
Cardioprotection Versus Gastrotoxicity: Finding a Balance to Advance Secondary Prevention of Cardiovascular Events With Aspirin
Supporter: Aralez Pharmaceuticals
Booth #751

Dietary and Pharmacologic Management of Electrolyte Disorders in Heart Failure
Supporter: Relypsa, Inc.
Booth #701

Roles of In-Hospital Worsening Heart Failure and End Organ Damage in Long-Term Outcomes
Supporter: Novartis
Booth #3661

These events are not part of the official Scientific Sessions as planned by the AHA Committee on Scientific Sessions Programming.

 

Top